Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply

The New England journal of medicine

Volumn 380, Issue 19, 2019, Pages 1881-1882

  Wiviott, Stephen D ^a   Raz, Itamar ^b   Sabatine, Marc S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; BENZHYDRYL DERIVATIVE; GLUCOSIDE;

HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

BENZHYDRYL COMPOUNDS; DIABETES MELLITUS, TYPE 2; GLUCOSIDES; HUMANS;

EID: 85065762329     PISSN: None     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1902837     Document Type: Letter

References (0)